When should we use abciximab in acute MI?
The video talks about the usage of abciximab in acute MI, by Dr. Viveka Kumar, Senior Director - Cath Lab, Max Super Speciality Hospital, Saket. Abciximab is a potent antiplatelet but its usage has gone down because nowadays there is an access to strong potent antiplatelets. The usage of injectable abciximab is in situations where there is no flow or huge thrombus burden. He will also discuss how and when the abciximab is given and when the patient has to be rechecked.
Dr. Viveka Kumar
Dr. Viveka Kumar is a Senior Consultant Interventional Cardiologist and Director of the Cath Lab at Max Super Speciality Hospital in Saket, New Delhi. He completed his MBBS and MD (Medicine) from IMS (BHU), Varanasi and later obtained the DM (Cardiology) postdoc, superspeciality degree through GSVM Medical College, Kanpur. Has extensive experience in the field of Cardiac interventions and Electrophysiology. Specializes in complex angioplasties including multivessel, bifurication and left main angioplasties with Rota Ablation, FFR, IVUS, IABP, IMPELLA devices. Has done more than 7500 angioplasties and 2500 balloon valvotomies with good outcomes.
More FAQs by Dr. Viveka Kumar
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article